Minimal brain dysfunctions in children.
D000661:Amphetamine / Q000627:therapeutic use; D001288:Attention; D001289:Attention Deficit Disorder with Hyperactivity / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003142:Communication; D004410:Dyslexia; D004644:Emotions; D005556:Form Perception; D006236:Handwriting; D006801:Humans; D006948:Hyperkinesis; D007099:Imipramine / Q000627:therapeutic use; D007361:Intelligence Tests; D007804:Language Development; D007859:Learning Disabilities; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D009048:Motor Skills; D009949:Orientation; D010389:Pemoline / Q000627:therapeutic use; D011596:Psychomotor Disorders; D013881:Thioridazine / Q000627:therapeutic use
D008774:Methylphenidate; D010389:Pemoline; D000661:Amphetamine; D013881:Thioridazine; D007099:Imipramine